XENOPHA
Live / Registered — Registered (as of 28 Sept 2021)
What this means for you
Registered since 28 Sept 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79298960
- Registration number
- 6495692
- Mark type
- Stylized text
- Filed
- 31 Aug 2020
- Published for opposition
- 13 Jul 2021
- Registered
- 28 Sept 2021
- Attorney of record
- Todd A. Denys
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for breast, thoracic, digestive, pelvic, plastic surgery and for human tissue repair, regeneration or strengthening; biological and surgical implants, namely, skin tissue, acellular dermal matrix and resorbing biopolymer intended for subsequent implantation; biological skin tissue implants intended for breast, thoracic, digestive, pelvic and plastic surgery; biological skin tissue implants intended for human tissue repair, regeneration or strengthening; acellular matrices in the nature of biological skin tissue used as implants intended for surgery biological skin tissue matrices for human tissue repair, regeneration or strengthening
Owner
- MECCELLIS BIOTECH, FR
- MECCELLIS BIOTECH, FR
- MECCELLIS BIOTECH, FR
Prosecution history
- 04 Apr 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 16 Mar 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 16 Mar 2022 — FINAL DISPOSITION PROCESSED
- 28 Dec 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 28 Sept 2021 — REGISTERED-PRINCIPAL REGISTER
- 19 Jul 2021 — NOTIFICATION PROCESSED BY IB
- 13 Jul 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jul 2021 — PUBLISHED FOR OPPOSITION
- 30 Jun 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 30 Jun 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 23 Jun 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Jun 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Jun 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Jun 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Jun 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED